RecruitingPhase 2NCT06831916

Impact of Cannabinoids on Menopause Symptoms

Effects of Hemp-Derived Cannabinoids on Menopause Symptoms


Sponsor

Washington State University

Enrollment

100 participants

Start Date

Mar 3, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of the study is to examine the impact of the hemp-derived minor cannabinoids on symptoms of menopause/perimenopause.


Eligibility

Sex: FEMALEMin Age: 40 YearsMax Age: 60 Years

Plain Language Summary

Simplified for easier understanding

This study is exploring whether cannabinoids (compounds found in cannabis) can help relieve menopause symptoms such as hot flashes, sleep problems, and mood changes in perimenopausal or menopausal women. Participants will receive a cannabinoid product and complete surveys via a smartphone app. **You may be eligible if...** - You were assigned female at birth and are between 40 and 60 years old - You are in perimenopause or menopause - You own a smartphone and have access to Zoom on a stable internet connection - You have not used cannabis regularly in the past year and are willing to abstain for 3 months - Your medications and supplement regimen have been stable for at least 3 months **You may NOT be eligible if...** - You currently take antidepressants, anti-anxiety medications, or antipsychotics - You have severe depression or are currently suicidal - You have a personal or family history of psychosis - You are pregnant or breastfeeding - You are currently receiving chemotherapy - You have low blood pressure (hypotension) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIETARY_SUPPLEMENTActive Cannabinoid Product

Participants will be administered a product with minor cannabinoids and terpenes.

OTHERPlacebo

Participants will be administered a placebo.


Locations(1)

Washington State University - Pullman Campus

Pullman, Washington, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06831916


Related Trials